IP Library Granted Patent US 10,463,711
Granted Patent B2
US 10,463,711 · App. 15/081,004 · Granted Nov 5, 2019

Nutritive polypeptides and formulations thereof, and methods of production and use thereof

Inventors: Michael Hamill (Wellesley, MA); Brett Boghigian (Boston, MA); Caitlyn Harvey (Wilmington, MA); David Berry (Brookline, MA); David Young (Portsmouth, NH); Geoffrey Von Maltzahn (Boston, MA); John Kramarczyk (Somerville, MA); Jameson Rogers (Cambridge, MA); Kathryn Heard (Watertown, MA); Michael Doherty (Somerville, MA); Nathaniel Silver (Cambridge, MA); Phillip Samayoa (Cambridge, MA); Subhayu Basu (Chestnut Hill, MA); Shaila Rahman (Cambridge, MA); Vimal Vaidya (Watertown, MA); Ying-Ja Chen (Cambridge, MA)
Assignee: Axcella Health Inc.
A61K38/1709A23L2/66A23L33/17A23L33/175A23L33/18A23L33/195A23L33/30A23L33/40A61K9/0053A61K9/0075A61K9/0095A61K9/146A61K9/2054A61K9/2866A61K38/00A61K38/10A61K38/16A61K38/164A61K38/168A61K38/17A61K38/1703A61K38/1767A61K38/38A61K38/45A61K45/06C12Y207/04003G01N33/6803G01N33/6806G01N33/6848G16B20/00A23V2002/00G01N2500/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,463,711
App. No.
15/081,004
Granted
Nov 5, 2019
Kind
B2
Abstract

Nutritive polypeptides are provided herein. Also provided are various other embodiments including nucleic acids encoding the polypeptides, recombinant microorganisms that make the polypeptides, vectors for expressing the polypeptides, methods of making the polypeptides using recombinant microorganisms, compositions and formulations that comprise the polypeptides, and methods of using the polypeptides, compositions and formulations.

Claims (18)

1. A method of increasing muscle anabolism in a human subject in need thereof, comprising administering to the human subject in one or more doses a nutritional formulation comprising an isolated nutritive polypeptide comprising an amino acid sequence corresponding to the sequence of SEQ ID NO:363; wherein the formulation comprises at least 1.0 g of the nutritive polypeptide; wherein the formulation is present as a liquid, semi-liquid or gel in a volume not greater than about 500 ml or as a solid or semi-solid in a total mass not greater than about 200 g; wherein the formulation is substantially free of non-comestible products, and wherein the nutritive polypeptide is present in the nutritional formulation in an amount sufficient to increase muscle anabolism in the subject after the administration thereof.

2. The method of claim 1 , wherein the nutritive polypeptide is at least 50%, 60%, 70%, 80% or 90% of the polypeptides present in the formulation.

3. The method of claim 1 , wherein the nutritive polypeptide is present in an amount sufficient to provide a nutritional benefit to the human subject and wherein the human subject is suffering from protein malnutrition or a disease, disorder or condition characterized by protein malnutrition.

4. The method of claim 1 , wherein the nutritive polypeptide is formulated in a pharmaceutically acceptable carrier.

5. The method of claim 1 , wherein the nutritive polypeptide is formulated in or as a food or a food ingredient, or as a medical food or as a medical food ingredient.

6. The method of claim 1 , wherein the nutritive polypeptide is formulated in or as a beverage or a beverage ingredient.

7. The method of claim 1 , wherein the amino acid sequence encodes an enzyme having an activity, and wherein the nutritive polypeptide lacks the activity.

8. The method of claim 1 , wherein the isolated nutritive polypeptide has an aqueous solubility at pH 7 of at least 12.5 g/L.

9. The method of claim 1 , wherein the isolated nutritive polypeptide has a simulated gastric digestion half-life of less than 30 minutes.

10. The method of claim 1 , wherein the formulation comprises a component selected from the group consisting of: a tastant, a protein mixture, a further polypeptide, a further peptide, a free amino acid, a carbohydrate, a lipid, a mineral or mineral source, a vitamin, a supplement, an organism, a pharmaceutical, and an excipient.

11. The method of claim 1 , wherein the nutritive polypeptide is secreted from a microorganism.

12. The method of claim 11 , wherein the nutritive polypeptide is secreted and purified from the microorganism.

13. The method of claim 11 , wherein the nutritive polypeptide is purified from one or more other polypeptides capable of being secreted by the microorganism.

14. The method of claim 11 , wherein the microorganism is selected from the group consisting of the genera Aspergillus, Trichoderma, Penicillium, Chrysosporium, Acremonium, Fusarium, Trametes , and Rhizopus.

15. The method of claim 11 , wherein the microorganism is selected from the group consisting of the genera Escherichia, Bacillus, Saccharomyces, Pichia, Corynebacterium, Syncchocystis, Synechococcus and Streptomyces.

16. The method of claim 1 , wherein the amino acid sequence is homologous to an enzyme having an activity, and wherein the nutritive polypeptide lacks the activity.

17. The method of claim 16 , wherein the nutritive polypeptide is thermostable at a pH of at least about 2.

18. The method of claim 16 , wherein the nutritive polypeptide is selected from the group consisting of: an enzyme-treated polypeptide, an acid-treated polypeptide, a base-treated polypeptide, a chemically-treated polypeptide, a heat-treated polypeptide, a detergent-treated polypeptide and combinations thereof.

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 20, 2023
From: AXCELLA HEALTH INC.
To: AXCELLA (ASSIGNMENT FOR THE BENEFIT OF CREDITORS), LLC
Reel/Frame 066125/0228 →
RELEASE OF SECURITY INTEREST Recorded Dec 15, 2022
From: SLR INVESTMENT CORP.
To: AXCELLA HEALTH INC.
Reel/Frame 062137/0569 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Sep 2, 2021
From: AXCELLA HEALTH INC.
To: SLR INVESTMENT CORP., AS AGENT
Reel/Frame 057435/0136 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 7, 2018
From: HAMILL, MICHAEL; BOGHIGIAN, BRETT; HARVEY, CAITLYN; BERRY, DAVID; YOUNG, DAVID; VON MALTZAHN, GEOFFREY; KRAMARCZYK, JOHN; ROGERS, JAMESON; HEARD, KATHRYN; DOHERTY, MICHAEL; SILVER, NATHANIEL; SAMAYOA, PHILLIP; BASU, SUBHAYU; RAHMAN, SHAILA; VAIDYA, VIMAL; CHEN, YING-JA
To: PRONUTRIA BIOSCIENCES, INC.
Reel/Frame 047708/0616 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 6, 2016
From: PRONUTRIA BIOSCIENCES, INC.
To: AXCELLA HEALTH INC.
Reel/Frame 040249/0741 →
Continuity (33)
Continuation In Part PCTUS2014057528 · Sep 25, 2014
Continuation In Part PCTUS2014057527 · Sep 25, 2014
Continuation In Part PCTUS2014057526 · Sep 25, 2014
Provisional Application 61906862 · Nov 20, 2013
Provisional Application 61682305 · Sep 25, 2013
Provisional Application 61882295 · Sep 25, 2013
Provisional Application 61882300 · Sep 25, 2013
Provisional Application 61882222 · Sep 25, 2013
Provisional Application 61882212 · Sep 25, 2013
Provisional Application 61882198 · Sep 25, 2013
Provisional Application 61882189 · Sep 25, 2013
Provisional Application 61882180 · Sep 25, 2013
Provisional Application 61882274 · Sep 25, 2013
Provisional Application 61882271 · Sep 25, 2013
Provisional Application 61882267 · Sep 25, 2013
Provisional Application 61882264 · Sep 25, 2013
Provisional Application 61882260 · Sep 25, 2013
Provisional Application 61882254 · Sep 25, 2013
Provisional Application 61882250 · Sep 25, 2013
Provisional Application 61882246 · Sep 25, 2013
Provisional Application 61882243 · Sep 25, 2013
Provisional Application 61882129 · Sep 25, 2013
Provisional Application 61882240 · Sep 25, 2013
Provisional Application 61882235 · Sep 25, 2013
Provisional Application 61882234 · Sep 25, 2013
Provisional Application 61882232 · Sep 25, 2013
Provisional Application 61882229 · Sep 25, 2013
Provisional Application 61882225 · Sep 25, 2013
Provisional Application 61882220 · Sep 25, 2013
Provisional Application 61882219 · Sep 25, 2013
Provisional Application 61882214 · Sep 25, 2013
Provisional Application 61882211 · Sep 25, 2013
Related Publication 20160339078A1 · Nov 24, 2016